Evidence There are no long-term RCTs, which leaves cohort and case-control studies as evidence. • The Society of Obstetricians and Gynaecologists of Canada1 and others2 have stated that evidence about the risk of VTE with different progestins is inconclusive owing to mixed results and a high risk of bias. • Some studies found no increased VTE risk with drospirenone3 or a transdermal patch.4 • S...

Our recent studies show that progestins induce vascular endothelial growth factor (VEGF) in breast cancer cells that express mutant p53 protein. Here, we show that natural and synthetic progestins also induce thrombospondin-1 (TSP-1) mRNA and protein in T47-D and BT-474 breast cancer cells. Antiprogestin RU-486 inhibits the induction of VEGF and TSP-1 by progestins, suggesting that this effect ...

Estrogen-containing hormone therapy (HT) is the most widely prescribed and well-established treatment for menopausal symptoms. High quality evidence confirms that estrogen effectively treats hot flushes, night sweats and vaginal dryness. Progestins are combined with estrogen to prevent endometrial hyperplasia and are sometimes used alone for hot flushes, but are less effective than estrogen for...

Currently, there are mounting data suggesting that HIV-1 acquisition in women can be affected by the use of certain hormonal contraceptives. However, in non-human primate models, endogenous or exogenous progestin-dominant states are shown to increase acquisition. To gain mechanistic insights into this increased acquisition, we studied how mucosal barrier function and CD4+ T-cell and CD68+ macro...

Previous investigations into the effects of progestins on copulatory behavior have suggested that progesterone inhibits the expression of androgen-dependent sexual behaviors in males. However, virtually all of those studies utilized pharmacological dosages of progesterone. Such experiments, although essential for understanding the behavioral effects of progesterone, yield little insight into th...

The ovarian steroid hormone, progesterone, and its nuclear receptor, the progesterone receptor, are implicated in the progression of breast cancer. Clinical trial data on the effects of hormone replacement therapy underscore the importance of understanding how progestins influence breast cancer growth. The progesterone receptor regulation of distinct target genes is mediated by complex interact...